Publication of a Prospectus

13th Jun 2025 14:48

RNS Number : 8438M
National Bank of Canada
13 June 2025
 

Regulatory Announcement

 

RNS Number: 8438M 

National Bank of Canada

13 June 2025

 

Publication of Prospectus

 

The following prospectus constitutes admission particulars for purposes of the International Securities Market Rulebook and is available for viewing:

 

Prospectus dated 13 June 2025 relating to the U.S.$25,000,000,000 Note Issuance Programme of National Bank of Canada (the "Prospectus").

 

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

The Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") or the securities laws of any state of the United States and are subject to United States tax law requirements. Subject to certain exceptions, the Notes may not be offered, sold or delivered, directly or indirectly, in the United States or to or for the account of a "U.S. person" (as defined in Regulation S under the Securities Act).  No public offering of the Notes is being made in the United States. This announcement does not constitute an offer to sell or a solicitation to buy securities in the United States or in any other jurisdiction where such offer or solicitation would be unlawful.

 

Your right to access this service is conditional upon complying with the above requirements.

 

To view the full Prospectus and the documents incorporated by reference therein, please paste the following URLs into the address bar of your browser:

 

Prospectus dated 13 June 2025

http://www.rns-pdf.londonstockexchange.com/rns/8438M_1-2025-6-13.pdf 

 

Documents partially or entirely incorporated by reference in the Prospectus:

 

2024 Annual Information Form

http://www.rns-pdf.londonstockexchange.com/rns/8438M_2-2025-6-13.pdf 

 

2024 Annual Report

http://www.rns-pdf.londonstockexchange.com/rns/8438M_3-2025-6-13.pdf 

 

2025 Second Quarter Report

http://www.rns-pdf.londonstockexchange.com/rns/8438M_4-2025-6-13.pdf 

 

Terms and Conditions from the 2024 Base Prospectus

http://www.rns-pdf.londonstockexchange.com/rns/8438M_5-2025-6-13.pdf 

 

Terms and Conditions from the 2023 Base Prospectus

http://www.rns-pdf.londonstockexchange.com/rns/8438M_6-2025-6-13.pdf 

 

Terms and Conditions from the 2022 Base Prospectus

http://www.rns-pdf.londonstockexchange.com/rns/8438M_7-2025-6-13.pdf 

 

Terms and Conditions from the First Prospectus Supplement to the 2022 Base Prospectus

http://www.rns-pdf.londonstockexchange.com/rns/8438M_8-2025-6-13.pdf 

 

Terms and Conditions from the 2021 Base Prospectus

http://www.rns-pdf.londonstockexchange.com/rns/8438M_9-2025-6-13.pdf 

 

Terms and Conditions from the 2020 Base Prospectus

http://www.rns-pdf.londonstockexchange.com/rns/8438M_10-2025-6-13.pdf 

 

Terms and Conditions from the Second Supplement to the 2020 Base Prospectus

http://www.rns-pdf.londonstockexchange.com/rns/8438M_11-2025-6-13.pdf

 

Terms and Conditions from the Fourth Supplement to the 2020 Base Prospectus

http://www.rns-pdf.londonstockexchange.com/rns/8438M_12-2025-6-13.pdf 

 

Terms and Conditions from the 2019 Base Prospectus

http://www.rns-pdf.londonstockexchange.com/rns/8438M_13-2025-6-13.pdf 

 

 

 

For further information, please contact:

 

Jean-Philippe Drolet

Managing Director and Head of Funding

National Bank of Canada

 

Phone: + 1 (514) 394 8242

Email: [email protected]

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIXXLFFEQLZBBF